Guardant Health (GH) Other financing activities (2017 - 2026)

Guardant Health has disclosed Other financing activities across 10 years of filings, most recently posting $26.1 million for Q2 2026.

• In Q2 2026, Other financing activities rose 276.92% year-over-year to $26.1 million; the TTM figure through Jun 2026 stood at $33.1 million (up 171.76% YoY), while the FY2025 annual figure was $19.2 million, up 64.03% from the prior year.
• Other financing activities came in at $26.1 million for Q2 2026 at Guardant Health, up from -$4.5 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $26.1 million in Q2 2026 to a low of -$4.5 million in Q1 2026.
• Average Other financing activities over 5 years is $5.1 million, with a median of $4.0 million recorded in 2022.
• Year-over-year, Other financing activities jumped 408.95% in 2022 and plunged 682.81% in 2026.
• Over 5 years, Other financing activities stood at $3.6 million in 2022, then slipped by 3.27% to $3.5 million in 2023, then jumped by 30.37% to $4.5 million in 2024, then jumped by 156.11% to $11.5 million in 2025, then jumped by 125.7% to $26.1 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $26.1 million in Q2 2026, -$4.5 million in Q1 2026, and $11.5 million in Q4 2025.